TG2: a credible therapeutic target in fibrotic diseasedue to its multifunctional roles

Martin Griffin, Zhuo Wang, Thomas Thibault, Colin Murdoch, Daniel Rathbone

Research output: Contribution to journalConference abstract

Abstract

The role of TG2 in fibrosis is reported to be related to two important effects. The first in mediating the deposition and accumulation of the fibrotic extracellular matrix (ECM) via its cross-linking of proteins like fibronectin, collagen I and collagen III; and the second, the activation of latent matrix bound TGFβ1. We report here that the role of TG2 in fibrosis progression can be much more complex.
We also report a new family of TG2-specific inhibitors that can not only inhibit protein cross-linking, but also regulate other functions of TG2, thus increasing their potency which can be demonstrated by their effectiveness in inhibiting fibrosis in two different fibrotic in vivo models.
Original languageEnglish
Pages (from-to)1629
Number of pages1
JournalAmino Acids
Volume47
Issue number8
Early online date14 Jul 2015
DOIs
Publication statusPublished - 31 Aug 2015
Event14th International Congress on Amino Acids, Peptides and Proteins - Vienna, Austria
Duration: 3 Aug 20157 Aug 2015

Bibliographical note

Abstracts presented at the 14th International Congress on Amino Acids, Peptides and Proteins, Vienna (AT), August 3–7, 2015.

Fingerprint Dive into the research topics of 'TG2: a credible therapeutic target in fibrotic diseasedue to its multifunctional roles'. Together they form a unique fingerprint.

  • Cite this